Treatment of Cyst Jialing River Acne with Isotretinoin Soft Capsule Combined with Qing-gan Qu-cuo Recipe

ZHU Li-ming

doi:10.13422/j.cnki.syfjx.2010.05.083

您当前的位置：

首页 >

文章列表页 >

Treatment of Cyst Jialing River Acne with Isotretinoin Soft Capsule Combined with Qing-gan Qu-cuo Recipe

更新时间：2024-09-23

- Treatment of Cyst Jialing River Acne with Isotretinoin Soft Capsule Combined with Qing-gan Qu-cuo Recipe
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 16, Issue 5, Pages: 211-213(2010)
- 作者机构：
  
  河南省洛阳市机车医院中西医结合科
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.2010.05.083
  CLC： R758.733
- Published：2010
- 稿件说明：
移动端阅览
[1]朱黎明.异维A酸胶丸联合清肝祛痤方治疗囊肿聚合性痤疮的临床观察[J].中国实验方剂学杂志,2010,16(05):211-213.

ZHU Li-ming. Treatment of Cyst Jialing River Acne with Isotretinoin Soft Capsule Combined with Qing-gan Qu-cuo Recipe[J]. Chinese journal of experimental traditional medical formulae, 2010, 16(5): 211-213.
[1]朱黎明.异维A酸胶丸联合清肝祛痤方治疗囊肿聚合性痤疮的临床观察[J].中国实验方剂学杂志,2010,16(05):211-213. DOI： 10.13422/j.cnki.syfjx.2010.05.083.

ZHU Li-ming. Treatment of Cyst Jialing River Acne with Isotretinoin Soft Capsule Combined with Qing-gan Qu-cuo Recipe[J]. Chinese journal of experimental traditional medical formulae, 2010, 16(5): 211-213. DOI： 10.13422/j.cnki.syfjx.2010.05.083.

摘要

目的:观察和研究异维A酸胶丸（泰尔丝）联合清肝祛痤方治疗囊肿聚合性痤疮的临床疗效。方法:50例囊肿聚合性痤疮患者随机分为两组

均给予异维A酸胶丸（泰尔丝）每次20mg

每天2次口服。治疗组（n=30）在此基础上加用清肝祛痤方

每日1剂

早晚分服

于治疗初始和2

8周时观察评价皮损改善

不良反应及16周时的复发情况。结果:治疗组有效率90.0%

对照组有效率45.0%。治疗组总皮损均数、炎症性皮损均数、非炎症性皮损均数治疗8周后与治疗前比较

差异有统计学意义（P<0.05或P<0.01）。对照组总皮损均数、炎症性皮损均数治疗8周后与治疗前比较

差异有统计学意义（P<0.05或P<0.01）

非炎症性皮损均数治疗8周后与治疗前比较

差异无统计学意义（P>0.05）。治疗组治疗8周后总皮损均数、非炎症性皮损均数与对照组相比较

差异有统计学意义（P<0.05或P<0.01）

炎症性皮损均数治疗后两组比较差异无显著性（P>0.05）。结论:异维A酸胶丸联合清肝祛痤方治疗囊肿聚合性痤疮疗效肯定

复发率低且不良反应少。

Abstract

Objective:To observe and study Isotretinoin soft capsules （TaiErSi） combined with Qing-gan Qu-cuo recipe in treating cyst jialing river acne. Method:50 patients cyst jialing river acne patients were randomly divided into two groups

Isotretinoin soft capsules （TaiErSi） 20mg

2 times every day. The treatment group （ n = 30） was added with qing-gan qu-cuo recipe daily. In the treatment of initial and 2

8 weeks

observing and studying the lesions’ recovery

assessing skin evaluation for 16 weeks and adverse reaction of recurrence. Result: The efficiency of treatment group and control group was 90. 0% vs 45. 0% . Total skin lesions means

inflammatory lesions means and noninflammatory lesions means of treatment group 8 weeks after treatment with before treatment

were statistically significant difference （P < 0. 05 or P < 0. 01）. The control group’s total skin lesions means and inflammatory skin lesions means of 8 weeks after treatment compared with before treatment were statistically significant differente （P < 0. 05 or P < 0. 01）

the noninflammatory lesions means of control group before and after treatment were no significant differente （ P > 0. 05 ）. 8 weeks after treatment

total skin lesions means and noninflammatory skin lesions means of treatment group are better than those of control group significantly（P < 0. 05 or P < 0. 01）

the inflammatory lesions means of both groups 8 weeks after treatment were no statistically significant difference between the two groups （P > 0. 05）. Conclusion:Isotretinoin soft capsules combined with qing-gan qucuo recipe in treating Cyst jialing river acne has reliable effect

low recurrent rate and less adverse reactions.

关键词

Keywords

references

Views

159

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Treatment of Cyst Jialing River Acne with Isotretinoin Soft Capsule Combined with Qing-gan Qu-cuo Recipe

Related Author

ZHU Li-ming

Related Institution

No data

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰